19 Active TrialsLarge Center
5 MS centers statewide · Ranked #1 in Maryland for clinical trials · #1 in Maryland for provider count
What kind of place is this?
Comprehensive Care TeamResearch FocusedPart of Major Health System
You're in an academic MS center that brings together neurology, rehabilitation, nursing, and social work in one place. You can expect detailed evaluation, imaging review, and access to pediatric MS expertise and precision medicine support.
Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research4/5
Insurance & Navigation Help3/5
Scheduling & Virtual Care2/5
About Johns Hopkins Multiple Sclerosis Center
This center combines adult MS care with a dedicated Pediatric Multiple Sclerosis, MOGAD and Neuroimmune Disorders Program. It also offers an MS Precision Medicine program, bringing advanced diagnostic and treatment planning tools into one academic setting.
Johns Hopkins Multiple Sclerosis Center cares for people with multiple sclerosis, relapsing-remitting MS, primary progressive MS, MOGAD, and pediatric neuroimmune disorders. Your evaluation may include MRI review, retinal scans, OCT, blood tests, genetic tests, and a detailed review of your medical history and lifestyle. Treatment options can include steroids, beta interferon, glatiramer acetate, medications, and rehabilitation therapies such as physical therapy, occupational therapy, and rehabilitation psychology. The center is part of Johns Hopkins Medicine and includes multidisciplinary support from neurologists, nurses, social workers, therapists, psychologists, and physicians. It also has a dedicated pediatric program and an MS Precision Medicine program.
Good to know
- Your first visit takes place at the Levi Watkins, Jr, MD, Outpatient Center.
- A physician referral is part of the appointment materials.
- The referral coordinator can accept records by fax at 410-367-3212.
- Please verify your insurance benefits before your visit.
- Bring MRI images of your brain and spinal cord to your appointment.
Johns Hopkins Multiple Sclerosis Center in Baltimore is part of Johns Hopkins Medicine and brings together specialists from several fields to support your care. You can be seen for targeted diagnosis, treatment planning, imaging review, rehabilitation, and pediatric MS care. The center offers programs for pediatric neuroimmune disorders, MS rehabilitation, and precision medicine. Patients benefit from a large academic team with deep experience in MS and related conditions.
Featured Care Team Members
Pavan Bhargava, MD
Active MS Prescriber
Michael Kornberg, M.D., Ph.D.
Active MS Prescriber
Justin McArthur, M.D.
Active MS Prescriber
Ellen Mowry, MD, MCR
Active MS Prescriber
Scott Newsome, D.O.
Active MS Prescriber
Bardia Nourbakhsh, MD
Active MS Prescriber
Specialized Programs
Pediatric Multiple Sclerosis, MOGAD and Neuroimmune Disorders Program
Multiple Sclerosis Rehabilitation
MS Precision Medicine Center of Excellence
Services & Treatments
What They Treat
multiple sclerosisrelapsing-remitting multiple sclerosisprimary progressive multiple sclerosispediatric neuroimmune disordersMOGAD
How They Treat It
targeted diagnosistreatment planningcomprehensive neurological evaluationMRI interpretationnursing assessmentphysical therapy assessmentsocial work assessmentpediatric MS careMS rehabilitationpatient resourcesappointments and referralssteroidsbeta interferonglatiramer acetateother FDA-approved drugs and therapiesphysical therapyoccupational therapyrehabilitation psychologymedications
Diagnostics
MRIretinal scansoptical coherence tomography (OCT)genetic testsblood testsmedical history reviewlifestyle assessments
Research & Clinical Trials
This center is currently involved in 19 clinical trials — ranked #1 in Maryland for active trials
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
Tiziana Life Sciences LTD
RECRUITINGPHASE2
ForalumabPlacebo
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)
Hoffmann-La Roche
RECRUITINGPHASE2
Ocrelizumab Test FormulationOcrelizumab Reference Formulation
A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
OcrelizumabOcrelizumab PlaceboFingolimodFingolimod Placebo
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibTeriflunomidePlacebo
ABA-101 in Participants With Progressive Multiple Sclerosis
Abata Therapeutics
ACTIVE NOT RECRUITINGPHASE1
ABA-101
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
UniQure Biopharma B.V.
RECRUITINGPHASE1, PHASE2
AAV9-hSyn1-miGRIK2
Biobank For MS And Other Demyelinating Diseases
Accelerated Cure Project for Multiple Sclerosis
ACTIVE NOT RECRUITING
Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis
The Cleveland Clinic
ACTIVE NOT RECRUITING
MRI
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS
MediciNova
ACTIVE NOT RECRUITINGPHASE2, PHASE3
MN-166placebo
Ketamine for Multiple Sclerosis Fatigue
Johns Hopkins University
ACTIVE NOT RECRUITINGPHASE2
KetamineMidazolam
Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab
Johns Hopkins University
ENROLLING BY INVITATION
Ofatumumab
Role of Genetic Factors in the Development of Lung Disease
National Heart, Lung, and Blood Institute (NHLBI)
RECRUITING
Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
Johns Hopkins University
RECRUITINGPHASE2
SolriamfetolPlacebo
Study of COYA 302 for the Treatment of ALS
Coya Therapeutics
RECRUITINGPHASE2
COYA 302Placebo
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
Immunic AG
ACTIVE NOT RECRUITINGPHASE2
IMU-838Placebo matching IMU-838
The Use of Technology to Improve MS Clinical Trials and Patient Care
Johns Hopkins University
ACTIVE NOT RECRUITINGNA
Communication with the clinic
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Johns Hopkins University
ACTIVE NOT RECRUITINGNA
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod
Insurance & Access
Insurance & Support
Care Coordinator
Related MS Research
Recent studies relevant to this center's focus areas
FAQs from Johns Hopkins Multiple Sclerosis Center
The center treats multiple sclerosis, relapsing-remitting MS, primary progressive MS, MOGAD, and pediatric neuroimmune disorders. It also offers pediatric MS care.
Your care may include MRI review, retinal scans, optical coherence tomography, blood tests, genetic tests, and a review of your medical history and lifestyle. The team also offers comprehensive neurological evaluation.
Treatment options include steroids, beta interferon, glatiramer acetate, other FDA-approved drugs and therapies, and medications. Rehabilitation support can include physical therapy, occupational therapy, and rehabilitation psychology.
Yes. Specialized programs include the Pediatric Multiple Sclerosis, MOGAD and Neuroimmune Disorders Program, Multiple Sclerosis Rehabilitation, and the MS Precision Medicine program.
You may need a physician referral and should bring MRI images of your brain and spinal cord. The referral coordinator can also accept records by fax at 410-367-3212.
Compare Maryland MS Centers
| Center | Type | Infusion | Virtual | Experience |
|---|---|---|---|---|
Johns Hopkins Multiple Sclerosis Center Baltimore | Academic MS Center | — | — | 3.2/5 |
| Academic MS Center | — | — | 3.4/5 | |
Clinre Comprehensive Neurology Frederick | Regional Neurology Group | — | — | 3.2/5 |
| Regional Neurology Group | — | — | 2.4/5 | |
International Neurorehabilitation Institute Lutherville | Regional Neurology Group | — | — | 3.8/5 |
Johns Hopkins Multiple Sclerosis Center
Baltimore • Academic MS Center
Infusion
—
Virtual
—
Experience
3.2/5
University of Maryland Center for Multiple Sclerosis
Baltimore • Academic MS Center
Infusion
—
Virtual
—
Experience
3.4/5
Clinre Comprehensive Neurology
Frederick • Regional Neurology Group
Infusion
—
Virtual
—
Experience
3.2/5
Sinai Neurology Associates at Brain and Spine Institute
Baltimore • Regional Neurology Group
Infusion
—
Virtual
—
Experience
2.4/5
International Neurorehabilitation Institute
Lutherville • Regional Neurology Group
Infusion
—
Virtual
—
Experience
3.8/5
MS Centers Across the U.S.
Click a state to browse its MS treatment centers.
Check out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
Information on this page is compiled from public sources including facility websites, ClinicalTrials.gov, CMS data, and AI analysis. It may not be complete or current. Always verify directly with the facility.